LEVI & KORSINSKY, LLP: FRAUD-ON-THE-MARKET DOCTRINE UNDERPINS ULTRAGENYX PHARMACEUTICAL SECURITIES CLASS ACTION

LEVI & KORSINSKY, LLP: FRAUD-ON-THE-MARKET DOCTRINE UNDERPINS ULTRAGENYX PHARMACEUTICAL SECURITIES CLASS ACTION Accessibility StatementSkip NavigationKnow Your Rights: How Basic Inc. v. Levinson Enables Investor RecoveryNEW YORK, March 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP announces that a securities class action has been filed against Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE).YOU MAY BE AFFECTED IF YOU:Lost money on your Ultragenyx investmentPurchased Ultragenyx stock between August 3, 2023 an ...